Renato Cozzi

Summary

Country: Italy

Publications

  1. ncbi Octreotide long-acting repeatable for acromegaly
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Via Canonica 81, I 20154 Milan, Italy
    Expert Rev Clin Pharmacol 5:125-43. 2012
  2. ncbi Pregnancy in acromegaly: a one-center experience
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    Eur J Endocrinol 155:279-84. 2006
  3. ncbi Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I 20149 Milan, Italy
    J Clin Endocrinol Metab 91:1397-403. 2006
  4. ncbi Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 27:1040-7. 2004
  5. ncbi Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Carlo Besta Institute, Milan, Italy
    Clin Endocrinol (Oxf) 61:209-15. 2004
  6. ncbi Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:3090-8. 2003
  7. ncbi Estroprogestinic pill normalizes IGF-I levels in acromegalic women
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 26:347-52. 2003
  8. ncbi Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly
    Roberto Attanasio
    Endocrinology Unit, Niguarda Hospital, I-20162 Milan, Italy
    J Clin Endocrinol Metab 88:5258-65. 2003
  9. ncbi Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    J Clin Endocrinol Metab 88:3105-12. 2003
  10. ncbi Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
    Cristina L Ronchi
    Department of Medical Sciences, University of Milan, Milan Unit of Endocrinology and Diabetology, Fondazione Ospedale Maggiore IRCCS, Milan, Italy
    Clin Endocrinol (Oxf) 71:846-52. 2009

Detail Information

Publications18

  1. ncbi Octreotide long-acting repeatable for acromegaly
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Via Canonica 81, I 20154 Milan, Italy
    Expert Rev Clin Pharmacol 5:125-43. 2012
    ..Treatment is well tolerated in most patients and can be safely prolonged for many years if required...
  2. ncbi Pregnancy in acromegaly: a one-center experience
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    Eur J Endocrinol 155:279-84. 2006
    ..The aim of the study was the retrospective evaluation of pregnancy in acromegalic women attending our center...
  3. ncbi Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I 20149 Milan, Italy
    J Clin Endocrinol Metab 91:1397-403. 2006
    ..Neurosurgery is regarded as the first-line treatment of acromegaly. Because of its low cure rate in macro and invasive adenoma, the role of primary medical treatment is debated...
  4. ncbi Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 27:1040-7. 2004
    ..The concordance between "safe" GH and normalised IGF-I levels during SA was also assessed, according to gender and gonadal status...
  5. ncbi Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, Carlo Besta Institute, Milan, Italy
    Clin Endocrinol (Oxf) 61:209-15. 2004
    ..Even though some data were reported about the addition of cabergoline, a long-acting dopamine agonist (DA), to SA in resistant patients, definite data are still lacking...
  6. ncbi Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
    Renato Cozzi
    Division of Endocrinology, Ospedale Niguarda, I 20162 Milan, Italy
    J Clin Endocrinol Metab 88:3090-8. 2003
    ....
  7. ncbi Estroprogestinic pill normalizes IGF-I levels in acromegalic women
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 26:347-52. 2003
    ..This pilot study shows a marked IGF-I lowering effect of pill in acromegalic women, and warrants a prospective randomized study in patients resistant or partially sensitive to other medical treatments...
  8. ncbi Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly
    Roberto Attanasio
    Endocrinology Unit, Niguarda Hospital, I-20162 Milan, Italy
    J Clin Endocrinol Metab 88:5258-65. 2003
    ....
  9. ncbi Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Milan, Italy
    J Clin Endocrinol Metab 88:3105-12. 2003
    ....
  10. ncbi Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study
    Cristina L Ronchi
    Department of Medical Sciences, University of Milan, Milan Unit of Endocrinology and Diabetology, Fondazione Ospedale Maggiore IRCCS, Milan, Italy
    Clin Endocrinol (Oxf) 71:846-52. 2009
    ..The long-term efficacy and safety of stereotactic radiosurgery by gamma knife (GK) still remain unknown. The aim of the study was to investigate the long-term efficacy and tolerability of GK in acromegalic patients...
  11. ncbi Raloxifene lowers IGF-I levels in acromegalic women
    Roberto Attanasio
    Division of Endocrinology, Ospedale Niguarda, Viale Ezio 5, I-20149 Milan, Italy
    Eur J Endocrinol 148:443-8. 2003
    ..e. with values lower than 600 microg/l) and normalizes it in many. A prospective randomized study in patients resistant or partially sensitive to other medical treatments is warranted...
  12. ncbi Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study
    Roberto Attanasio
    Division of Endocrinology, Joined Hospitals of Bergamo, Italy Pituitary Unit, Galeazzi Institute IRCCS, Milan, Italy
    Endocr Pract 14:846-55. 2008
    ..To evaluate the safety and effectiveness of lanreotide Autogel on growth hormone and insulinlike growth factor 1 (IGF-1) concentrations and tumor size in patients with acromegaly...
  13. ncbi GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide
    R Attanasio
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    J Endocrinol Invest 24:209-16. 2001
    ....
  14. ncbi A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    Eur J Endocrinol 141:267-71. 1999
    ....
  15. ncbi Lanreotide 60 mg, a longer-acting somatostatin analog: tumor shrinkage and hormonal normalization in acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Milan, Italy
    Pituitary 3:231-8. 2000
    ..Somatostatin analogues are nowadays the milestone in the medical treatment of acromegaly. We evaluated the effects of a new 60 mg longer-acting formulation of lanreotide (LAN60) on GH/IGF-I levels and tumor size...
  16. ncbi Failure of radiotherapy in acromegaly
    R Cozzi
    Division of Endocrinology, Niguarda Hospital, Neurological Institute Carlo Besta, Milan, Italy
    Eur J Endocrinol 145:717-26. 2001
    ..Recent data has raised skepticism regarding the long-term effectiveness of radiotherapy (RxT) in acromegaly and its role as an ancillary tool to neurosurgery (Tx)...
  17. ncbi Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
    Annamaria Colao
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Via S Pansini 5, 80131 Naples, Italy
    J Clin Endocrinol Metab 91:85-92. 2006
    ..Surgery is a cornerstone in the treatment of acromegaly, but its efficacy in large, invasive tumors is scant...
  18. ncbi Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy
    Massimo Terzolo
    Dipartimento de Scienze Cliniche e Biologische, Clinica Medica, Universita di Torino, Italy
    J Clin Endocrinol Metab 90:84-90. 2005
    ..Patients who are found to harbor a colonic neoplasia are at risk for recurrence...